Immunobiology of Merkel cell carcinoma: implications for immunotherapy of a polyomavirus-associated cancer

nork Bhatia, Shailender, Afanasiev, Olga, Nghiem, Paul
Argitaratua 2011

Treatment of Metastatic Melanoma: An Overview

nork BHATIA, SHAILENDER, TYKODI, SCOTT S., THOMPSON, JOHN A.
Argitaratua 2009

Harnessing Natural Killer Cells in Cancer Immunotherapy: A Review of Mechanisms and Novel Therapies

nork St-Pierre, Frederique, Bhatia, Shailender, Chandra, Sunandana
Argitaratua izan da Cancers (Basel) (2021)

Immunotherapy for Merkel cell carcinoma: a turning point in patient care

nork Chan, Isaac S., Bhatia, Shailender, Kaufman, Howard L., Lipson, Evan J.
Argitaratua izan da J Immunother Cancer (2018)

Emerging and Mechanism-Based Therapies for Recurrent or Metastatic Merkel Cell Carcinoma

nork Miller, Natalie J., Bhatia, Shailender, Parvathaneni, Upendra, Iyer, Jayasri G., Nghiem, Paul
Argitaratua 2013

Systemic therapy of brain metastases: non–small cell lung cancer, breast cancer, and melanoma

nork Chamberlain, Marc C., Baik, Christina S., Gadi, Vijayakrishna K., Bhatia, Shailender, Chow, Laura Q.M.
Argitaratua izan da Neuro Oncol (2017)

Clinical Benefit from Tyrosine Kinase Inhibitors in Metastatic Merkel Cell Carcinoma: A Case Series of 5 Patients

nork Tarabadkar, Erica S., Thomas, Hannah, Blom, Astrid, Parvathaneni, Upendra, Olencki, Thomas, Nghiem, Paul, Bhatia, Shailender
Argitaratua izan da Am J Case Rep (2018)

Economics of alternative dosing strategies for pembrolizumab and nivolumab at a single academic cancer center

nork Hall, Evan, Zhang, Jenny, Kim, Eun Jeong, Hwang, Grace, Chu, Gilbert, Bhatia, Shailender, Reddy, Sunil
Argitaratua izan da Cancer Med (2020)

Immune evasion mechanisms and immune checkpoint inhibition in advanced merkel cell carcinoma

nork Schadendorf, Dirk, Nghiem, Paul, Bhatia, Shailender, Hauschild, Axel, Saiag, Philippe, Mahnke, Lisa, Hariharan, Subramanian, Kaufman, Howard L.
Argitaratua izan da Oncoimmunology (2017)

Intratumoral electroporation of plasmid interleukin-12: efficacy and biomarker analyses from a phase 2 study in melanoma (OMS-I100)

nork Daud, Adil, Algazi, Alain, Ashworth, Michelle, Buljan, Michael, Takamura, Kathryn Toshimi, Diep, Tu, Pierce, Robert H, Bhatia, Shailender
Argitaratua izan da J Transl Med (2015)

Untangling the Multidisciplinary Care Web: Streamlining Care through an Immune-Related Adverse Events (IRAE) Tumor Board

nork Kennedy, Laura C., Wong, Kit Man, Kamat, Nik, Khaki, Ali Raza, Bhatia, Shailender, Thompson, John A., Grivas, Petros
Argitaratua izan da Target Oncol (2020)

How we treat Merkel cell carcinoma: within and beyond current guidelines

nork Park, Song Y, Doolittle-Amieva, Coley, Moshiri, Yasman, Akaike, Tomoko, Parvathaneni, Upendra, Bhatia, Shailender, Zaba, Lisa C, Nghiem, Paul
Argitaratua izan da Future Oncol (2021)

Clinical Utility of a Circulating Tumor Cell Assay in Merkel cell carcinoma

nork Blom, Astrid, Bhatia, Shailender, Pietromonaco, Stephanie, Koehler, Karen, Iyer, Jayasri G., Nagase, Kotaro, Paulson, Kelly, Sabath, Daniel E., Nghiem, Paul
Argitaratua 2013

Paraneoplastic syndromes associated with Merkel cell carcinoma: A case series of eight patients highlighting different clinical manifestations

nork Iyer, Jayasri, Parvathaneni, Kaushik, Bhatia, Shailender, Shantha, Erica, Blom, Astrid, Doumani, Ryan, McKenzie, Jill, Asgari, Maryam M., Nghiem, Paul
Argitaratua izan da J Am Acad Dermatol (2016)

Phase II Trial of Sorafenib in Combination with Carboplatin and Paclitaxel in Patients with Metastatic Uveal Melanoma: SWOG S0512

nork Bhatia, Shailender, Moon, James, Margolin, Kim A., Weber, Jeffrey S., Lao, Christopher D., Othus, Megan, Aparicio, Ana M., Ribas, Antoni, Sondak, Vernon K.
Argitaratua 2012

A phase I study of the investigational NEDD8-activating enzyme inhibitor pevonedistat (TAK-924/MLN4924) in patients with metastatic melanoma

nork Bhatia, Shailender, Pavlick, Anna C., Boasberg, Peter, Thompson, John A., Mulligan, George, Pickard, Michael D., Faessel, Hélène, Dezube, Bruce J., Hamid, Omid
Argitaratua izan da Invest New Drugs (2016)

Phase I study of IMGN901, a CD56-targeting antibody-drug conjugate, in patients with CD56-positive solid tumors

nork Shah, Manisha H., Lorigan, Paul, O’Brien, Mary E. R., Fossella, Frank V., Moore, Kathleen N., Bhatia, Shailender, Kirby, Maurice, Woll, Penella J.
Argitaratua izan da Invest New Drugs (2016)

Response rates and durability of chemotherapy among 62 patients with metastatic Merkel cell carcinoma

nork Iyer, Jayasri G., Blom, Astrid, Doumani, Ryan, Lewis, Christopher, Tarabadkar, Erica S., Anderson, Austin, Ma, Christine, Bestick, Amy, Parvathaneni, Upendra, Bhatia, Shailender, Nghiem, Paul
Argitaratua izan da Cancer Med (2016)

Rescue therapy for patients with anti-PD-1-refractory Merkel cell carcinoma: a multicenter, retrospective case series

nork LoPiccolo, Jaclyn, Schollenberger, Megan D., Dakhil, Sumia, Rosner, Samuel, Ali, Osama, Sharfman, William H., Silk, Ann W., Bhatia, Shailender, Lipson, Evan J.
Argitaratua izan da J Immunother Cancer (2019)

Fatal enteric plexus neuropathy after one dose of ipilimumab plus nivolumab: a case report

nork Appelbaum, Jacob, Wells, David, Hiatt, Joseph B., Steinbach, Gideon, Stewart, F. Marc, Thomas, Hannah, Nghiem, Paul, Kapur, Raj P., Thompson, John A., Bhatia, Shailender
Argitaratua izan da J Immunother Cancer (2018)